Principal Investigator
Overview
Body Locations and Systems
Diagnosis and Therapy
ClinicalTrials.gov#
NCT04710576
Status
Closed for Recruitment
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Edward Wong, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the efficacy, safety and tolerability of axatilimab at three different dose levels in participants with recurrent or refractory active chronic graft versus host disease (cGVHD) who have received at least two prior lines of systemic therapy.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Body Locations and Systems
Diagnosis and Therapy
ClinicalTrials.gov#
NCT04710576
Status
Closed for Recruitment
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Edward Wong, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the efficacy, safety and tolerability of axatilimab at three different dose levels in participants with recurrent or refractory active chronic graft versus host disease (cGVHD) who have received at least two prior lines of systemic therapy.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
